We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
25 Jun 2026 - 27 Jun 2026
08 Jul 2026 - 10 Jul 2026

DakoCytomation Acquires Gastric Ulcer Test

By HospiMedica staff writers
Posted on 15 Sep 2003
The rights to a test detecting the ulcer-causing bacteria Helicobactor pylori have been acquired by DakoCytomation (Copenhagen, Denmark) from Connex GmbH (Martinsried, Germany), a biotechnology company.

According to the agreement, DakoCytomation will handle continued production, sales, distribution, and customer service of the test, which will become part of DakoCytomation's diagnostic portfolio. More...
The H pylori antibodies are used in a test that is an enzyme-linked immunosorbent assay (ELISA). Compared to other tests, this method is noninvasive and because it is cost effective, more patients will be able to receive optimal treatment, states DakoCytomation.

"Acquisition of the H pylori rights is strategically important to us; we continuously aim at expanding and strengthening our proprietary pool of key intellectual property rights to better serve our customers and secure our continued development and growth,” said Erik Winther, executive vice president and CFO of DakoCytomation.





Related Links:
DakoCytomation
Connex

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hybrid Arch Device
Neo EDE
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.